304 related articles for article (PubMed ID: 9176387)
1. Abnormal expression of the cell cycle regulators P16 and CDK4 in Alzheimer's disease.
McShea A; Harris PL; Webster KR; Wahl AF; Smith MA
Am J Pathol; 1997 Jun; 150(6):1933-9. PubMed ID: 9176387
[TBL] [Abstract][Full Text] [Related]
2. Neuronal expression of cycline dependent kinase inhibitors of the INK4 family in Alzheimer's disease.
Arendt T; Holzer M; Gärtner U
J Neural Transm (Vienna); 1998; 105(8-9):949-60. PubMed ID: 9869328
[TBL] [Abstract][Full Text] [Related]
3. Expression of the cyclin-dependent kinase inhibitor p16 in Alzheimer's disease.
Arendt T; Rödel L; Gärtner U; Holzer M
Neuroreport; 1996 Nov; 7(18):3047-9. PubMed ID: 9116237
[TBL] [Abstract][Full Text] [Related]
4. Cyclin-dependent kinase 5 immunoreactivity for granulovacuolar degeneration.
Nakamori M; Takahashi T; Yamazaki Y; Kurashige T; Yamawaki T; Matsumoto M
Neuroreport; 2012 Oct; 23(15):867-72. PubMed ID: 22968343
[TBL] [Abstract][Full Text] [Related]
5. Elevated expression of a regulator of the G2/M phase of the cell cycle, neuronal CIP-1-associated regulator of cyclin B, in Alzheimer's disease.
Zhu X; McShea A; Harris PL; Raina AK; Castellani RJ; Funk JO; Shah S; Atwood C; Bowen R; Bowser R; Morelli L; Perry G; Smith MA
J Neurosci Res; 2004 Mar; 75(5):698-703. PubMed ID: 14991845
[TBL] [Abstract][Full Text] [Related]
6. Regulation of cyclin-dependent kinase 4 during adipogenesis involves switching of cyclin D subunits and concurrent binding of p18INK4c and p27Kip1.
Phelps DE; Xiong Y
Cell Growth Differ; 1998 Aug; 9(8):595-610. PubMed ID: 9716177
[TBL] [Abstract][Full Text] [Related]
7. Direct binding of the N-terminus of HTLV-1 tax oncoprotein to cyclin-dependent kinase 4 is a dominant path to stimulate the kinase activity.
Li J; Li H; Tsai MD
Biochemistry; 2003 Jun; 42(22):6921-8. PubMed ID: 12779347
[TBL] [Abstract][Full Text] [Related]
8. Survivin initiates cell cycle entry by the competitive interaction with Cdk4/p16(INK4a) and Cdk2/cyclin E complex activation.
Suzuki A; Hayashida M; Ito T; Kawano H; Nakano T; Miura M; Akahane K; Shiraki K
Oncogene; 2000 Jul; 19(29):3225-34. PubMed ID: 10918579
[TBL] [Abstract][Full Text] [Related]
9. Characterization of the cyclin-dependent kinase inhibitory domain of the INK4 family as a model for a synthetic tumour suppressor molecule.
Fåhraeus R; Laín S; Ball KL; Lane DP
Oncogene; 1998 Feb; 16(5):587-96. PubMed ID: 9482104
[TBL] [Abstract][Full Text] [Related]
10. A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4.
Serrano M; Hannon GJ; Beach D
Nature; 1993 Dec; 366(6456):704-7. PubMed ID: 8259215
[TBL] [Abstract][Full Text] [Related]
11. Expression of INK4 inhibitors of cyclin D-dependent kinases during mouse brain development.
Zindy F; Soares H; Herzog KH; Morgan J; Sherr CJ; Roussel MF
Cell Growth Differ; 1997 Nov; 8(11):1139-50. PubMed ID: 9372237
[TBL] [Abstract][Full Text] [Related]
12. The E2F-family proteins induce distinct cell cycle regulatory factors in p16-arrested, U343 astrocytoma cells.
Dirks PB; Rutka JT; Hubbard SL; Mondal S; Hamel PA
Oncogene; 1998 Aug; 17(7):867-76. PubMed ID: 9780003
[TBL] [Abstract][Full Text] [Related]
13. Analysis of p16INK4a and its interaction with CDK4.
Yang R; Serrano M; Slater J; Leung E; Koeffler HP
Biochem Biophys Res Commun; 1996 Jan; 218(1):254-9. PubMed ID: 8573142
[TBL] [Abstract][Full Text] [Related]
14. Ectopic cell cycle proteins predict the sites of neuronal cell death in Alzheimer's disease brain.
Busser J; Geldmacher DS; Herrup K
J Neurosci; 1998 Apr; 18(8):2801-7. PubMed ID: 9525997
[TBL] [Abstract][Full Text] [Related]
15. Increased p27, an essential component of cell cycle control, in Alzheimer's disease.
Ogawa O; Lee HG; Zhu X; Raina A; Harris PL; Castellani RJ; Perry G; Smith MA
Aging Cell; 2003 Apr; 2(2):105-10. PubMed ID: 12882323
[TBL] [Abstract][Full Text] [Related]
16. p16 proteins from melanoma-prone families are deficient in binding to Cdk4.
Reymond A; Brent R
Oncogene; 1995 Sep; 11(6):1173-8. PubMed ID: 7566978
[TBL] [Abstract][Full Text] [Related]
17. Structural characterization of the tumor suppressor p16, an ankyrin-like repeat protein.
Boice JA; Fairman R
Protein Sci; 1996 Sep; 5(9):1776-84. PubMed ID: 8880901
[TBL] [Abstract][Full Text] [Related]
18. Adenovirus-mediated overexpression of p15INK4B inhibits human glioma cell growth, induces replicative senescence, and inhibits telomerase activity similarly to p16INK4A.
Fuxe J; Akusjärvi G; Goike HM; Roos G; Collins VP; Pettersson RF
Cell Growth Differ; 2000 Jul; 11(7):373-84. PubMed ID: 10939591
[TBL] [Abstract][Full Text] [Related]
19. Cell cycle inhibitors (p27Kip1 and p21CIP1) cause hypertrophy in LLC-PK1 cells.
Terada Y; Inoshita S; Nakashima O; Tamamori M; Ito H; Kuwahara M; Sasaki S; Marumo F
Kidney Int; 1999 Aug; 56(2):494-501. PubMed ID: 10432388
[TBL] [Abstract][Full Text] [Related]
20. Ubiquitin/proteasome-mediated degradation of p19INK4d determines its periodic expression during the cell cycle.
Thullberg M; Bartek J; Lukas J
Oncogene; 2000 Jun; 19(24):2870-6. PubMed ID: 10851091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
